Trovensis Injection

Trovensis Injection

ondansetron

Manufacturer:

Sanbe
Concise Prescribing Info
Contents
Ondansetron
Indications/Uses
Management of nausea & vomiting induced by chemotherapy & radiotherapy. Post-op nausea & vomiting.
Dosage/Direction for Use
Prevention of nausea & vomiting associated w/ moderately emetogenic cancer chemotherapy Adult 8 mg twice daily. Administer 1st dose 30 min prior to chemotherapy w/ subsequent dose 4-8 hrly. Thereafter, 8 mg twice daily for 1-2 days after completion of chemotherapy. Childn 4-12 yr 4 mg 3 times daily. Prevention of nausea & vomiting associated w/ radiotherapy 8 mg 1-2 hr prior to radiotherapy w/ subsequent doses 8 hrly after the 1st dose. Post-op nausea & vomiting 16 mg as single dose 1 hr prior to anaesth induction.
Special Precautions
Pregnancy & lactation.
Adverse Reactions
Constipation, headache, diarrhea; flushing, warm sensation in the head & epigastrium. Rarely, rash, tachycardia, angina.
Drug Interactions
Cytochrome P-450 inducers & inhibitors.
ATC Classification
A04AA01 - ondansetron ; Belongs to the class of serotonin (5HT3) antagonists. Used for the prevention of nausea and vomiting.
Presentation/Packing
Form
Trovensis Injection 8 mg/4 mL
Packing/Price
5 × 1's (Rp335,300.00/boks)
Form
Trovensis Injection 4 mg/2 mL
Packing/Price
5 × 1's (Rp165,000.00/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in